Biased research, aggressive sales, harmful drugs
The Health Policy Exchange
MAY 20, 2013
Unfortunately, recent case studies have illustrated that FDA approval does not necessarily provide assurances of effectiveness and safety. government agencies do more to protect patients from the effects of biased research and aggressive sales tactics for newly marketed drugs? The size of average doses would more than triple.
130 
Let's personalize your content